Show simple item record

dc.contributor.authorSu, Xingfang
dc.contributor.authorFricke, Jennifer
dc.contributor.authorKavanagh, Daniel G.
dc.contributor.authorIrvine, Darrell J
dc.date.accessioned2013-08-02T16:27:50Z
dc.date.available2013-08-02T16:27:50Z
dc.date.issued2011-06
dc.date.submitted2011-02
dc.identifier.issn1543-8384
dc.identifier.issn1543-8392
dc.identifier.urihttp://hdl.handle.net/1721.1/79764
dc.description.abstractBiodegradable core−shell structured nanoparticles with a poly(β-amino ester) (PBAE) core enveloped by a phospholipid bilayer shell were developed for in vivo mRNA delivery with a view toward delivery of mRNA-based vaccines. The pH-responsive PBAE component was chosen to promote endosome disruption, while the lipid surface layer was selected to minimize toxicity of the polycation core. Messenger RNA was efficiently adsorbed via electrostatic interactions onto the surface of these net positively charged nanoparticles. In vitro, mRNA-loaded particle uptake by dendritic cells led to mRNA delivery into the cytosol with low cytotoxicity, followed by translation of the encoded protein in these difficult-to-transfect cells at a frequency of 30%. Particles loaded with mRNA administered intranasally (i.n.) in mice led to the expression of the reporter protein luciferase in vivo as soon as 6 h after administration, a time point when naked mRNA given i.n. showed no expression. At later time points, luciferase expression was detected in naked mRNA-treated mice, but this group showed a wide variation in levels of transfection, compared to particle-treated mice. This system may thus be promising for noninvasive delivery of mRNA-based vaccines.en_US
dc.description.sponsorshipUnited States. Dept. of Defense (Institute for Soldier Nanotechnology, contract W911NF-07-D-0004)en_US
dc.description.sponsorshipRagon Institute of MGH, MIT and Harvarden_US
dc.description.sponsorshipSingapore. Agency for Science, Technology and Researchen_US
dc.description.sponsorshipHoward Hughes Medical Institute (Investigator)en_US
dc.language.isoen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.isversionofhttp://dx.doi.org/10.1021/mp100390wen_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alike 3.0en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.sourcePubMed Centralen_US
dc.titleIn vitro and in vivo mRNA delivery using lipid-enveloped pHresponsive polymer nanoparticlesen_US
dc.typeArticleen_US
dc.identifier.citationSu, Xingfang, Jennifer Fricke, Daniel G. Kavanagh, and Darrell J. Irvine. “In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles.” Molecular Pharmaceutics 8, no. 3 (June 6, 2011): 774-787.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Materials Science and Engineeringen_US
dc.contributor.departmentRagon Institute of MGH, MIT and Harvarden_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorSu, Xingfangen_US
dc.contributor.mitauthorFricke, Jenniferen_US
dc.contributor.mitauthorKavanagh, Daniel G.en_US
dc.contributor.mitauthorIrvine, Darrell J.en_US
dc.relation.journalMolecular Pharmaceuticsen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsSu, Xingfang; Fricke, Jennifer; Kavanagh, Daniel G.; Irvine, Darrell J.en_US
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record